Pharming Group NV Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Morgan Stanley has filed an amended Schedule 13G, indicating its beneficial ownership in Pharming Group N.V. has decreased to 1.2% as of March 31, 2025, falling below the 5% reporting threshold.